The elevated pulmonary artery pressure in PAH is an outcome of pathological processes that involve the purinergic receptors P2Y, as a member of the G protein–coupled receptors family (GPCRs) [5,6,7,8,9,10,11,12,13]. Here, P2RY1 is linked to pulmonary arterial hypertension.